RyboDyn, Inc. Unveils New Proteome and Secures $4M Funding to Combat Cancer RyboDyn, Inc. has recently discovered a novel human proteome and secured $4 million in pre-seed funding aimed at advancing cancer therapies using groundbreaking RNA sequencing.

RyboDyn, Inc. Unveils New Proteome and Secures $4M Funding to Combat Cancer #USA #San_Diego #Cancer_Immunotherapy #RyboDyn #Dark_Genome